Michael Scolaro

Michael Scolaro

Sep 23, 2017

Group 6 Copy 254
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Impact of Soylent Consumption on Human Microbiome Composition

    As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

    A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

    The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

    Ebola video voice-over recording in 10 African local languages

    Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

    Backer Badge Funded